🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 28/11/1977 | 0,0113 USD |
| 29/08/1977 | 0,0099 USD |
| 31/05/1977 | 0,0099 USD |
| 01/03/1977 | 0,0099 USD |
| 30/11/1976 | 0,0099 USD |
| 30/08/1976 | 0,0093 USD |
| 01/06/1976 | 0,0093 USD |
| 02/03/1976 | 0,0093 USD |
| 01/12/1975 | 0,0093 USD |
| 29/08/1975 | 0,0093 USD |
| 02/06/1975 | 0,0093 USD |
| 03/03/1975 | 0,0093 USD |
| 30/08/1974 | 0,0093 USD |
| 03/06/1974 | 0,0093 USD |
| 04/03/1974 | 0,0093 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 09/09/1976 | 2,02 | 2,03 | 2,01 | 2,02 | +0,00% | 0,98% | 1.527.984 |
| 08/09/1976 | 2,02 | 2,03 | 2,01 | 2,02 | -0,17% | 1,15% | 1.735.488 |
| 07/09/1976 | 2,00 | 2,02 | 1,99 | 2,02 | +1,16% | 1,66% | 1.531.757 |
| 03/09/1976 | 1,98 | 2,00 | 1,97 | 2,00 | +1,00% | 1,68% | 1.135.613 |
| 02/09/1976 | 1,98 | 2,00 | 1,98 | 1,98 | -0,17% | 1,00% | 2.803.190 |
| 01/09/1976 | 1,94 | 1,99 | 1,94 | 1,98 | +2,57% | 2,39% | 2.791.872 |
| 31/08/1976 | 1,93 | 1,94 | 1,93 | 1,93 | +0,69% | 0,86% | 1.120.522 |
| 30/08/1976 | 1,91 | 1,93 | 1,91 | 1,92 | +0,70% | 1,22% | 1.441.210 |
| 27/08/1976 | 1,91 | 1,92 | 1,89 | 1,91 | +0,17% | 1,22% | 709.286 |
| 26/08/1976 | 1,91 | 1,91 | 1,90 | 1,91 | -0,35% | 0,52% | 852.653 |
| 25/08/1976 | 1,90 | 1,92 | 1,89 | 1,91 | +0,70% | 1,22% | 1.384.618 |
| 24/08/1976 | 1,90 | 1,91 | 1,90 | 1,90 | +0,18% | 0,70% | 999.792 |
| 23/08/1976 | 1,90 | 1,90 | 1,86 | 1,90 | -0,52% | 2,27% | 1.671.350 |
| 20/08/1976 | 1,92 | 1,92 | 1,90 | 1,91 | -1,03% | 1,04% | 863.971 |
| 19/08/1976 | 1,95 | 1,96 | 1,93 | 1,93 | -1,52% | 1,86% | 958.291 |
| 18/08/1976 | 1,95 | 1,97 | 1,95 | 1,95 | +0,00% | 0,84% | 1.897.718 |
| 17/08/1976 | 1,95 | 1,97 | 1,95 | 1,95 | +0,17% | 1,36% | 1.456.301 |
| 16/08/1976 | 1,92 | 1,95 | 1,91 | 1,95 | +1,55% | 2,07% | 1.082.794 |
| 13/08/1976 | 1,92 | 1,93 | 1,91 | 1,92 | +0,35% | 1,04% | 973.382 |
| 12/08/1976 | 1,92 | 1,92 | 1,91 | 1,92 | +0,00% | 0,52% | 709.286 |
| 11/08/1976 | 1,92 | 1,92 | 1,91 | 1,92 | +0,00% | 0,52% | 1.060.157 |
| 10/08/1976 | 1,90 | 1,92 | 1,90 | 1,92 | +1,05% | 1,05% | 1.294.070 |
| 09/08/1976 | 1,91 | 1,91 | 1,89 | 1,90 | -0,52% | 0,87% | 1.312.934 |
| 06/08/1976 | 1,89 | 1,91 | 1,89 | 1,91 | +0,88% | 0,88% | 773.424 |
| 05/08/1976 | 1,89 | 1,91 | 1,88 | 1,89 | +0,00% | 1,58% | 837.562 |
| 04/08/1976 | 1,89 | 1,91 | 1,89 | 1,89 | -0,17% | 1,23% | 1.312.934 |
| 03/08/1976 | 1,87 | 1,90 | 1,87 | 1,89 | +1,96% | 1,42% | 1.037.520 |
| 02/08/1976 | 1,86 | 1,87 | 1,86 | 1,86 | +0,00% | 0,89% | 671.558 |
| 30/07/1976 | 1,84 | 1,86 | 1,84 | 1,86 | +0,90% | 0,72% | 841.334 |
| 29/07/1976 | 1,85 | 1,85 | 1,83 | 1,84 | -0,72% | 0,89% | 999.792 |